Asthma – HealthQuill

Israel’s Teva Pharmaceutical Industries, and US-based Launch Therapeutics, have joined hands to speed up the development of an experimental asthma drug.

New treatment for severe asthma attacks in 50 years

Bharti Jayshankar November 29, 2024: Around half a billion people live with asthma and chronic obstructive pulmonary disease (COPD). The Global Burden of.

by HealthQuill
November 29, 2024
0 Comments

Sixty percent of the patients treated with Pfizer’s Lorbrena drug, for a rare form of advanced lung cancer, were alive without disease progression after five years, according to company data.

Health Uncategorized

Review finds links between allergic diseases and mental health conditions

HQ Team November 15, 2024:Allergies are a source of great social and physical impairment for people suffering from them. Treatments are long-drawn, expensive.

by HealthQuill
November 15, 2024
0 Comments

The US Food and Drug Administration has greenlighted Pfizer Inc.’s respiratory syncytial virus vaccine (RSV) Abrysvo for treating lower respiratory tract disease in people 18-59 years.

Drugs Health Pharma

US drug regulator FDA approves expanded use of Pfizer’s RSV vaccine

The US Food and Drug Administration has greenlighted Pfizer Inc.’s respiratory syncytial virus vaccine (RSV) Abrysvo for treating lower respiratory tract disease in.

by HealthQuill
October 23, 2024
0 Comments

China’s drug regulator, the National Medical Products Association, has approved AstraZeneca Plc’s asthma drug.

Drugs Health Pharma

AstraZeneca’s asthma drug gets regulator’s approval in China

China’s drug regulator, the National Medical Products Association, has approved AstraZeneca Plc’s asthma drug.

by HealthQuill
August 20, 2024
0 Comments

The European Medicines Agency has approved Sanofi S.A.’s Dupixent (dupilumab) therapy as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease, according to a company statement.

Drugs Health Pharma

EMA approves Sanofi’s treatment for obstructive pulmonary disease

The European Medicines Agency has approved Sanofi S.A.’s Dupixent (dupilumab) therapy as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary.

by HealthQuill
July 4, 2024
0 Comments

Johnson & Johnson will acquire Proteologix, Inc., a privately-held biotechnology company, for $850 million in cash, according to a statement.

Drugs Health Pharma

Johnson & Johnson to buy Proteologix Inc., for $850 million in cash

HQ Team May 17, 2024: Johnson & Johnson will acquire Proteologix, Inc., a privately-held biotechnology company, for $850 million in cash, according to.

by HealthQuill
May 17, 2024
0 Comments

Drugs Health Medical

NO2 in gas and propane stoves can cause asthma in children: Study

HQ Team May 4, 2024: A new research says that nitrogen dioxide gas (NO2) emitted by gas and propane stoves is likely to.

by HealthQuill
May 4, 2024
0 Comments

Drugs Health Pharma

Israel’s Teva in pact with Launch Therapeutics for asthma drug

Israel’s Teva Pharmaceutical Industries, and US-based Launch Therapeutics, have joined hands to speed up the development of an experimental asthma drug.

by HealthQuill
April 2, 2024
0 Comments

British drugmaker GSK Plc., will pay $1.4 billion to acquire Anglo-American biopharmaceutical company Aiolos Bio Inc., which makes medicines to treat asthma.

Drugs Health Pharma

GSK Plc., to buy asthma drugmaker Aiolos Bio for $1.4 billion

HQ Team January 9, 2023: British drugmaker GSK Plc., will pay $1.4 billion to acquire Anglo-American biopharmaceutical company Aiolos Bio Inc., which makes.